Detalhe da pesquisa
1.
Lung Oligometastasis of Breast Cancer: Prospective Cohort Study of Treatment Strategies (SBP-06).
Acta Med Okayama
; 78(1): 15-20, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38419310
2.
Impact of Immediate Breast Reconstruction on Survival of Breast Cancer Patients: A Single-Center Observational Study.
Acta Med Okayama
; 77(3): 281-290, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37357629
3.
Gene Expression Profiling between Patient Groups with High and Low Ki67 Levels after Short-term Preoperative Aromatase Inhibitor Treatment for Breast Cancer.
Acta Med Okayama
; 76(4): 399-408, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36123154
4.
Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments.
Breast Cancer Res Treat
; 185(2): 307-316, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33034801
5.
Risk factors of local recurrence following implant-based breast reconstruction in breast cancer patients.
BMC Womens Health
; 21(1): 147, 2021 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33838670
6.
Optimizing the timing of 3.6 mg Pegfilgrastim Administration for Dose-Dense Chemotherapy in Japanese Patients with Breast Cancer.
Acta Med Okayama
; 75(3): 357-362, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34176940
7.
Long-Term Physical Activity and Body Composition After Exercise and Educational Programs for Breast Cancer: A Randomized Controlled Trial From the Setouchi Breast Project-10.
Clin Breast Cancer
; 24(1): 27-35.e8, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37852895
8.
Predictive value of immune genomic signatures from breast cancer cohorts containing data for both response to neoadjuvant chemotherapy and prognosis after surgery.
Breast Cancer
; 30(1): 56-67, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35994199
9.
Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer.
Breast Cancer
; 30(5): 856-868, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37422608
10.
A Case Report on Apocrine Encapsulated Papillary Carcinoma of the Breast with Frank Invasion: A Diagnostic Quandary.
Int J Surg Pathol
; 30(8): 939-944, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35491656
11.
Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
Breast Cancer
; 28(2): 478-487, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33185851
12.
Biomarkers of neoadjuvant/adjuvant chemotherapy for breast cancer.
Chin Clin Oncol
; 9(3): 27, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32192349
13.
Nab-Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide in Neoadjuvant Chemotherapy for Resectable Breast Cancer: A Phase II Trial.
World J Oncol
; 11(5): 197-203, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33117463
14.
Recurring radiation-induced angiosarcoma of the breast that was treated with paclitaxel chemotherapy: a case report.
Surg Case Rep
; 6(1): 25, 2020 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31950295
15.
Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
Clin Breast Cancer
; 20(2): 117-124.e4, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570267
16.
Clinical Predictive Factors for the Efficacy of Everolimus in Patients With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer: A Multicenter Retrospective Cohort Study in Japan.
Breast Cancer (Auckl)
; 13: 1178223418825135, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733627
17.
The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancer.
Breast Cancer
; 25(6): 717-722, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29948957
18.
The Sexual Dimorphism of Dietary Restriction Responsiveness in Caenorhabditis elegans.
Cell Rep
; 21(13): 3646-3652, 2017 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29281814